Page last updated: 2024-08-26

3,4-methylenedioxyethamphetamine and Chronic Illness

3,4-methylenedioxyethamphetamine has been researched along with Chronic Illness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Merrill, J1
Saunders, N1

Other Studies

2 other study(ies) available for 3,4-methylenedioxyethamphetamine and Chronic Illness

ArticleYear
Ecstasy and neurodegeneration. Advice is that "less is more".
    BMJ (Clinical research ed.), 1996, Aug-17, Volume: 313, Issue:7054

    Topics: 3,4-Methylenedioxyamphetamine; Chronic Disease; Designer Drugs; Humans; Nervous System Diseases; Risk Factors

1996
Ecstasy and neurodegeneration. No evidence of neurotoxicity exists.
    BMJ (Clinical research ed.), 1996, Aug-17, Volume: 313, Issue:7054

    Topics: 3,4-Methylenedioxyamphetamine; Brain Diseases; Chronic Disease; Designer Drugs; Humans; Nervous System Diseases

1996